These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18324485)

  • 1. The inflammatory Th 17 subset in immunity against self and non-self antigens.
    Jin D; Zhang L; Zheng J; Zhao Y
    Autoimmunity; 2008 Mar; 41(2):154-62. PubMed ID: 18324485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17 cell induction and immune regulatory effects.
    Bi Y; Liu G; Yang R
    J Cell Physiol; 2007 May; 211(2):273-8. PubMed ID: 17311299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes.
    Chung Y; Yang X; Chang SH; Ma L; Tian Q; Dong C
    Cell Res; 2006 Nov; 16(11):902-7. PubMed ID: 17088898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
    Kikly K; Liu L; Na S; Sedgwick JD
    Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells.
    Castellani ML; Anogeianaki A; Felaco P; Toniato E; De Lutiis MA; Shaik B; Fulcheri M; Vecchiet J; Tetè S; Salini V; Theoharides TC; Caraffa A; Antinolfi P; Frydas I; Conti P; Cuccurullo C; Ciampoli C; Cerulli G; Kempuraj D
    J Biol Regul Homeost Agents; 2010; 24(2):131-5. PubMed ID: 20487626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T helper cells plasticity in inflammation.
    Cosmi L; Maggi L; Santarlasci V; Liotta F; Annunziato F
    Cytometry A; 2014 Jan; 85(1):36-42. PubMed ID: 24009159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-23/IL-17 biology and therapeutic considerations.
    Dong C
    J Immunotoxicol; 2008 Jan; 5(1):43-6. PubMed ID: 18382857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
    Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
    Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental plasticity of Th17 and Treg cells.
    Lee YK; Mukasa R; Hatton RD; Weaver CT
    Curr Opin Immunol; 2009 Jun; 21(3):274-80. PubMed ID: 19524429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer.
    Miyahara Y; Odunsi K; Chen W; Peng G; Matsuzaki J; Wang RF
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15505-10. PubMed ID: 18832156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cell differentiation: the long and winding road.
    McGeachy MJ; Cua DJ
    Immunity; 2008 Apr; 28(4):445-53. PubMed ID: 18400187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2008 Jul; 58(7):2196-205. PubMed ID: 18576340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
    Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
    J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.